Zepbound KwikPen (Tirzepatide) NDC 0002-3566

Product information

Brand name (proprietary)

Zepbound KwikPenSuffix: KwikPen

Generic name (nonproprietary)

tirzepatide

Active ingredients

Tirzepatide — 4.17 mg/mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

Eli Lilly and CompanyNDC labeler code 0002

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 217806

Marketing start

Jan 20, 2026

Listing expires

Dec 31, 2027

Other FDA classes

G-Protein-linked Receptor Interactions (Mechanism)Glucagon-like Peptide-1 (GLP-1) Agonists (Mechanism)

Identifiers

Product ID 0002-3566_a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fcSPL ID a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fcSPL set ID 487cd7e7-434c-4925-99fa-aa80b1cc776bRxCUI 2601743, 2601755, 2601761, 2601767, 2601773, 2601784, 2644396, 2644401, 2644405, 2644409, 2644413, 2644417, 2669706, 2669709, 2669712, 2669715, 2669718, 2669721, 2679317, 2679319, 2679321, 2679323, 2679325, 2679327, 2732437, 2732440, 2732442, 2732444, 2732446, 2732448, 2732449, 2732450, 2732452, 2732454, 2732456, 2732458, 2734623, 2734626, 2734628, 2734630, 2734632, 2734634, 2734636, 2734638, 2734640, 2734642, 2734644, 2734646UNII OYN3CCI6QEUPC 0300022002045, 0300026210118, 0300021423049, 0300020152049, 0300026052114, 0300021214043, 0300026103113, 0300026612110, 0300021340049, 0300026304114, 0300026523119, 0300020243044

Pharmacologic class

GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

No drug-specific HCPCS code in Med-Code’s directory for this product.

Med-Code's directory has no drug-specific HCPCS code for Zepbound. It is usually self-administered and billed by NDC through a pharmacy benefit.

If a payer accepts an unclassified code for it in a clinical setting, that would be J3490 (Unclassified drugs), with the NDC, quantity and often the invoice. Acceptance varies by payer.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002356611 followed by a unit qualifier and the quantity Copy

Package 00002-3566-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

About NDC 0002-3566

What is NDC 0002-3566?

0002-3566 is the product NDC for Zepbound KwikPen (tirzepatide), Tirzepatide 4.17 mg/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Zepbound KwikPen (Tirzepatide).

What is the active ingredient?

Tirzepatide.

Who is the labeler?

Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zepbound KwikPen?

5 other product NDCs are listed under this name. See all Zepbound KwikPen NDCs.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory. See Billing references above.

Related NDCs: other Zepbound KwikPen products

Other finished products listed under the same name: strengths, forms and labelers.

Other NDCs under NDA 217806

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 23.